ArticleAlgorithms for molecular biology : AMB2014
Simplified sequence-based method for ATP-binding prediction using contextual local evolutionary conservation.
Article in Algorithms for molecular biology : AMB, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Accurate prediction of protein-ATP binding sites based on a protein pretrained large language model and a fractional-order convolutional neural network.Scientific reports · 2025Article
- Prediction of Protein-ATP Binding Residues Based on Ensemble of Deep Convolutional Neural Networks and LightGBM Algorithm.International journal of molecular sciences · 2021Article
- Harnessing the evolutionary information on oxygen binding proteins through Support Vector Machines based modules.BMC research notes · 2018Article
- Protein ligand-specific binding residue predictions by an ensemble classifier.BMC bioinformatics · 2016Article
- Determining microbial products and identifying molecular targets in the human microbiome.Cell metabolism · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdentifying ligand-binding sites is a key step to annotate the protein functions and to find applications in drug design. Now, many sequence-based methods adopted various predicted results from other classifiers, such as predicted secondary structure, predicted solvent accessibility and predicted disorder probabilities, to combine with position-specific scoring matrix (PSSM) as input for binding sites prediction. These predicted features not only easily result in high-dimensional feature space, but also greatly increased the complexity of algorithms. Moreover, the performances of these predictors are also largely influenced by the other classifiers.
resultsIn order to verify that conservation is the most powerful attribute in identifying ligand-binding sites, and to show the importance of revising PSSM to match the detailed conservation pattern of functional site in prediction, we have analyzed the Adenosine-5'-triphosphate (ATP) ligand as an example, and proposed a simple method for ATP-binding sites prediction, named as CLCLpred (Contextual Local evolutionary Conservation-based method for Ligand-binding prediction). Our method employed no predicted results from other classifiers as input; all used features were extracted from PSSM only. We tested our method on 2 separate data sets. Experimental results showed that, comparing with other 9 existing methods on the same data sets, our method achieved the best performance.
conclusionsThis study demonstrates that: 1) exploiting the signal from the detailed conservation pattern of residues will largely facilitate the prediction of protein functional sites; and 2) the local evolutionary conservation enables accurate prediction of ATP-binding sites directly from protein sequence.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.